Zurich Cantonal Bank’s Altimmune ALT Stock Holding History

Zurich Cantonal Bank’s Portfolio ALT Stock Details ALT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-1,125	Closed	-$4.06K	–	2588
2025 Q4	$4.06K	Buy	+1,125	New	+$4.9K	﹤0.01%	2505

Other funds holding ALT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Zurich Cantonal Bank's ALT Position: Q4 2025 in Review

Zurich Cantonal Bank sold out of Altimmune (ALT) in Q4 2025, closing a stake of 1,125 shares — an estimated $4.9K sold.

Zurich Cantonal Bank first reported a position in ALT in Q4 2022 and held it in 12 quarters. The position peaked at $175K in Q4 2022. 181 funds tracked by Wall St. Rank hold ALT as of Q4 2025.

Zurich Cantonal Bank reported no remaining Altimmune position as of Q4 2025 after selling out during the quarter.
Zurich Cantonal Bank sold 1,125 Altimmune shares in Q4 2025, an estimated $4.9K.
Zurich Cantonal Bank first reported a position in Altimmune in Q4 2022 and held it in 12 quarters.
Zurich Cantonal Bank's Altimmune position peaked at $175K in Q4 2022.
181 funds tracked by Wall St. Rank held Altimmune as of Q4 2025.

Based on Zurich Cantonal Bank's 13F filing for Q4 2025, filed 27 Jan 2026.